Multimodal Analgesia and Outcomes in Hysterectomy Surgery—A Population-Based Analysis
-
Published:2024-09-13
Issue:18
Volume:13
Page:5431
-
ISSN:2077-0383
-
Container-title:Journal of Clinical Medicine
-
language:en
-
Short-container-title:JCM
Author:
Cozowicz Crispiana1ORCID, Gerner Hannah D.2, Zhong Haoyan3, Illescas Alex3, Reisinger Lisa3, Poeran Jashvant3, Liu Jiabin34, Memtsoudis Stavros G.134
Affiliation:
1. Department of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Muellner Hauptstrasse 48, 5020 Salzburg, Austria 2. Medical University of Graz, Neue Stiftingtalstrasse 6, 8010 Graz, Austria 3. Department of Anesthesiology, Critical Care & Pain Management, Weill Cornell Medical College, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA 4. Department of Anesthesiology, Weill Cornell Medicine, New York, NY 10021, USA
Abstract
Objective: We aimed to investigate the impact of multimodal analgesia on postoperative complications and opioid prescription on a national level. Methods: This retrospective cross-sectional study included n = 1,307,923 hysterectomies (01/2006–12/2022, Premier Healthcare claims data). Multimodal analgesia was defined as opioid use with the addition of non-opioid analgesic modes, grouped into four categories: opioid-only and 1, 2, or 3 or more additional non-opioid analgesics. Multivariable regression models measured associations between multimodal categories and outcomes (composite/respiratory/cardiac/gastrointestinal/genitourinary, and CNS complications, oral morphine milligram equivalents [MME], and length of hospital stay [LOS]). Odds ratios (OR) and 95% confidence intervals (CI) are reported. Results: Overall, 84.3% (1,102,812/1,307,923) received multimodal analgesia, of which 58.9%, 28.0%, and 13.1% received 1, 2, or 3 or more additional non-opioid analgesics, respectively. The odds of any composite complication (any ≥1 complication) decreased with the addition of 1, 2, 3, or more analgesic modalities (versus opioid-only): OR 0.66 (CI 0.64; 0.68), OR 0.63 (CI 0.61; 0.66), OR 0.65 (CI 0.62; 0.67), respectively. Similar patterns existed for respiratory, cardiac, and genitourinary complications. Opioid prescription decreased incrementally with 1,2, 3, or more non-opioid analgesic modalities by 9.51 mg (CI 11.16; 7.86) and 15.29 mg (CI 17.21; 13.37) and 29.35 mg (CI 31.79; 26.91) cumulative MME. LOS was reduced by 0.52 days (CI 0.54; 0.51), 0.49 days (CI 0.51; 0.47), and 0.40 days (CI 0.43; 0.38), respectively. Costs were reduced by $765 (CI 817; 714) or $479 (CI 539; 419) with 1 or 2 multimodal modes. Conclusions: These findings suggest substantial benefits of multimodal analgesia, including significant decreases in serious complications (especially respiratory, cardiac, and genitourinary), opioid consumption, and hospitalizations. Multimodal analgesia may facilitate safe and efficient pain management with optimized opioid consumption.
Funder
Research and Education Fund, Department of Anesthesiology, Critical Care and Pain, Hospital for Special Surgery
Reference28 articles.
1. Trends and predictors of hysterectomy prevalence among women in the United States;Harvey;Am. J. Obstet. Gynecol.,2022 2. Chronic pain after hysterectomy;Brandsborg;Curr. Opin. Anaesthesiol.,2018 3. Enhanced recovery after surgery (eras) in gynecologic oncology: System-wide implementation and audit leads to improved value and patient outcomes;Bisch;Gynecol. Oncol.,2018 4. Association of multimodal pain management strategies with perioperative outcomes and resource utilization: A population-based study;Memtsoudis;Anesthesiology,2018 5. Cozowicz, C., Zhong, H., Poeran, J., Illescas, A., Liu, J., Poultsides, L.A., Avgerinos, D.V., and Memtsoudis, S.G. The impact of multimodal analgesia in coronary artery bypass graft surgery-a population-based analysis. J. Thorac. Cardiovasc. Surg., 2023. in press.
|
|